Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Enterovirus A vaccine - Adimmune/Medigen Vaccine Biologics

Next Previous
Drug Profile

Enterovirus A vaccine - Adimmune/Medigen Vaccine Biologics

Alternative Names: EV-71 vaccine; EV71 vaccine inactivated - Medigen; Inactive whole monovalent EV71 virion vaccine

Latest Information Update: 06 Jan 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator National Health Research Institutes
  • Developer Adimmune Corporation; Medigen Vaccine Biologics; National Health Research Institutes
  • Class Enterovirus vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III Enterovirus A infections

Most Recent Events

  • 06 Jan 2025 Phase-III development is ongoing in Enterovirus A infections (In children, In infants, Prevention) in Vietnam and Taiwan (IM, Injection) (NCT05099029)
  • 11 Dec 2021 Medigen Vaccine Biologics completes an observational extension trial in Enterovirus A infections (Prevention, In children) in Taiwan (FU-EV21e; NCT04072276)
  • 16 Apr 2021 Medigen Vaccine Biologics completes a phase III clinical trial in Enterovirus A infections (In children, In infants, Prevention) in Taiwan and Vietnam (IM) (NCT03865238)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top